The NF-κB RelB Protein Is an Oncogenic Driver of Mesenchymal Glioma
High-grade gliomas, such as glioblastomas (GBMs), are very aggressive, invasive brain tumors with low patient survival rates. The recent identification of distinct glioma tumor subtypes offers the potential for understanding disease pathogenesis, responses to treatment and identification of molecula...
Main Authors: | Lee, Dong Whan, Ramakrishnan, Dhivya, Valenta, John, Parney, Ian F., Bayless, Kayla J., Sitcheran, Raquel |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581451/ |
Similar Items
-
p50–NF-κB Complexes Partially Compensate for the Absence of RelB: Severely Increased Pathology in p50−
/−
relB−
/−Double-knockout Mice
by: Weih, Falk, et al.
Published: (1997) -
Control of RelB during dendritic cell activation integrates canonical and non-canonical NF-κB pathways
by: Shih, Vincent F.-S., et al.
Published: (2012) -
The RelB subunit of NFκB acts as a negative regulator of circadian gene expression
by: Bellet, Marina M., et al.
Published: (2012) -
Aryl hydrocarbon receptor signaling regulates NF-κB RelB activation during dendritic-cell differentiation
by: Vogel, Christoph F A, et al.
Published: (2013) -
RelB/NF-κB links cell cycle transition and apoptosis to endometrioid adenocarcinoma tumorigenesis
by: Ge, Qiu-Lin, et al.
Published: (2016)